QR code

Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence

ObjectivesTo investigate the association between anti-obesity medication (AOM) use and the risk of cognitive disorder in individuals with overweight and obesity.MethodsWe systematically searched PubMed, Embase, the Cochrane Central Register of Controlled Trials, Web of Science and Clinicaltrials.gov...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Chengwen Li, Chu Lin, Zonglin Li, Fang Lv, Wenjia Yang, Linong Ji, Xiaoling Cai
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2026-06-01
Reeks:Frontiers in Pharmacology
Onderwerpen:
alzheimer’s disease
anti-obesity medications
cognitive disorder
dementia
meta-analysis
Online toegang:https://www.frontiersin.org/articles/10.3389/fphar.2026.1859388/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items